NRC announced the availability of and seeks comment on a draft report, "Consolidated Decommissioning Guidance, Characterization, Survey, and Determination of Radiological Criteria," that has been revised to address lessons learned and experience gained since the last revision to the document in September 2006.

EPA submitted to USDA a draft regulatory document titled “Pesticide Product Performance Data Requirements for Products Claiming Efficacy Against Certain Invertebrate Pests.”

NRC announced and seeks comment on a proposed policy statement titled NRC Enforcement Policy.

United States v. Seattle, City of, No.16-1486 (W.D. Wash. Nov. 12, 2020). A settling CERCLA, CWA, and OPA defendant that damaged natural resources by releasing hazardous substances from city facilities along the Lower Duwamish Waterway must purchase restoration credits, establish conservation easements on parcels along the waterway, pay $91,000 of the damage assessment costs, and pay to operate and maintain a restoration project. 

EPA entered into a proposed stipulated partial settlement agreement under the ESA concerning its alleged failure to consult on the effects to listed species of certain pesticide product registrations.

EPA proposed to amend significant new use rules for certain chemical substances to allow certain new uses and modify significant new use notification requirements.

NRC announced and seeks comment on a draft report that revises and explains the formula for determining the minimum decommissioning fund requirements for nuclear power reactor licensees. 

EPA finalized revisions to the agricultural worker protection standard to simplify pesticide application exclusion zone requirements.

EPA announced the availability of and seeks comment on a draft guidance document that provides information to pesticide registrants concerning the Agency’s consideration to expand the potential for data waivers for acute dermal toxicity studies to single technical active ingredients used to formulate end use products.

EPA announced the availability of the final TSCA risk evaluation of cyclic aliphatic bromide cluster (HBCD); the evaluation determined that specific conditions of use of HBCD present an unreasonable risk of injury to health or the environment that EPA must address through risk management measures enumerated in TSCA, and determined that other specific conditions of use do not present unreasonable risk of injury to health or the environment.